Policy & Regulation

Focus on opthalmology: new treatment modality

Interviewee/Contributer: Patrik de Haes

Organisation: ThromboGenics

Full text available to subscribers only. Click here for information on subscribing to MedNous.

What reforms are needed for the EU clinical trials directive

Interviewee/Contributer: Kate Law

Organisation: Cancer Research UK

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The outlook for new clinical trial legislation in Europe

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

UK Biotech needs a subtle culture shift

Interviewee/Contributer: Karen Finn

Organisation: Mednous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

FDA lays out regulatory science strategy

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Denmark has introduced new procedures for ADRs

Interviewee/Contributer: Henrik Jensen

Organisation: Danish Medicines Agency

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Developing biosimilar monoclonal antibodies will not be easy

Interviewee/Contributer: Gabriele Schaffner-Dallmann

Organisation: Pharmatching GmbH

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Securing Europe's lead in vaccine research

Interviewee/Contributer: Ruxandra Draghia-Akli

Organisation: European Commission

Full text available to subscribers only. Click here for information on subscribing to MedNous.

EMA guidance on biosimilar monoclonal antibodies

Interviewee/Contributer: Cecil Nick

Organisation: Parexel

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Proposed UK 'patent box' unveiled

Interviewee/Contributer: Mark Watterson

Organisation: Simmons and Simmons LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content